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Upon ras activation, ornithine decarboxylase (ODC) is markedly 
induced, and numerous studies suggest that ODC expression is controlled by 
Ras effector pathways. ODC is therefore a potential target in the treatment 
and prevention of Ras-driven tumors. We compared ODC mRNA translation 
profiles and stability in normal and Ras12V-transformed rat intestinal 
epithelial (RIE-1) cells. While translation initiation of ODC increased modestly 
in Ras12V cells, ODC RNA was stabilized 8-fold. Treatment with the specific 
mTORC1 inhibitor rapamycin or siRNA knockdown of mTOR destabilized the 
ODC message, but rapamycin had only a minor effect on ODC translation 
initiation. Inhibition of mTORC1 also reduced the association of the mRNA 
binding protein HuR with the ODC transcript. We have shown previously that 
HuR binding to the ODC 3′UTR results in significant stabilization of the ODC 
mRNA, which contains several AU- rich regions within its 3′UTR that may act 
as regulatory sequences. Analysis of ODC 3′UTR deletion constructs suggests 
that cis-acting elements between bases 1969 and 2141 of the ODC mRNA act 
to stabilize the ODC transcript. These experiments thus define a novel 
mechanism of ODC synthesis control. Regulation of ODC mRNA decay could 
be an important means of limiting polyamine accumulation and subsequent 
tumor development. 
Keywords: ornithine decarboxylase, mRNA stability, translation initiation, 
mTOR, rapamycin, HuR 
INTRODUCTION 
Increased activity of ornithine decarboxylase (ODC), the first 
biosynthetic enzyme of the polyamine pathway, has been 
demonstrated in a variety of human malignancies, including prostate 
cancer, squamous cell carcinoma of the skin and colon cancer 
(reviewed in [1]). Intracellular levels of ODC are tightly regulated, and 
multiple means of ODC dysregulation can occur in response to 
oncogenic stimuli. We have used in vitro and in vivo models of Ras 
activation to establish that ODC activity is regulated by and necessary 
for Ras-dependent cellular transformation, as well as transformation 
brought about by the Ras effectors MEK and eIF4E [2–5]. Activation of 
ODC transcription and protein synthesis is dependent on pathways 
downstream of Raf/MEK/ERK and PI3K/mTOR in both fibroblast and 
epithelial models [3, 6]. The cooperation of pathways controlled by Raf 
and PI3K/mTOR is necessary for complete Ras transformation of 
several types of epithelial cells (reviewed in [7]). Since most solid 
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tumors are epithelial in origin, understanding how ODC synthesis is 
controlled by these pathways is crucial in defining the role of ODC in 
maintaining a transformed phenotype. 
Cap-dependent translational regulation of ODC through its 5′-
untranslated region (5′UTR) is well-established, and ODC activity and 
translation are induced in eIF4E-overexpressing fibroblasts (4E-P2 
cells) [2, 8]. However, our studies in rat intestinal epithelial cells (RIE-
1 cells) described here suggest an alternate post-transcriptional 
regulatory mechanism for ODC protein synthesis. In this system, ODC 
synthesis is regulated primarily by changes in the levels of ODC RNA 
associated with polysomes, rather than changes in translation 
initiation. The mechanism of this regulation is a marked stabilization of 
the ODC mRNA in Ras12V-transformed RIE-1 cells (Ras12V cells) 
compared to their nontransformed parental controls, which appears to 
be regulated at least in part by pathways downstream of mTOR 
Complex 1 (mTORC1). Although the primary function of mTORC1 is in 
controlling the availability of eIF4E for translation initiation (reviewed 
in [9]), several studies show that TOR inhibition results in RNA 
stabilization. In S. Cerevisiae inhibition of TORC1 using the specific 
inhibitor rapamycin induced destabilization of multiple mRNAs, 
suggesting that TORC1 functions also involve regulation of mRNA 
turnover [10, 11]. In mammalian systems, rapamycin treatment of 
mouse embryo fibroblasts increased the degradation of mRNAs 
corresponding to Cyclin D1 and c-Myc in an Akt-dependent manner 
[12], while treatment of breast cancer MDA-MB-231 cells with 
rapamycin resulted in destabilization of IL-8 mRNA [13]. 
Regulation of mRNA stability is recognized to play a pivotal role 
in controlling gene expression. Sequences defined as adenylate- and 
uridylate-rich elements (AREs), which are classified based on the 
number and context of the sequence 5′-AUUUA-3′, are present within 
the 3′UTRs of many proto-oncogene, transcription factor and cytokine 
mRNAs (reviewed in [14, 15]), and can act as determinants of mRNA 
stability. The mouse, rat and human ODC 3′UTR sequences, each of 
which is between 600–700 bases in length, have several potential 
AREs within approximately 300 bases the stop codon. A number of 
regulatory proteins are known to interact with ARE sequences. These 
proteins not only control transcript decay, but can also influence 
translational efficiency, or cause the bound RNA transcript to move to 
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a processing body (P-body) for storage [16]. We have shown recently 
that the ubiquitous member of the ELAV protein family HuR associates 
with ODC mRNA in transformed cells and causes the ODC transcript to 
be stabilized [17]. Our results described here suggest that changes in 
ODC mRNA stability are mediated by cis-acting elements within the 
ODC 3′UTR and pathways downstream of mTORC1 play a role in this 
regulation at least in part by controlling the association of HuR with 
the ODC transcript. 
EXPERIMENTAL 
Cell culture and inhibitors 
RIE-1 cells (a kind gift of Dr. Kenneth Brown, University of 
Cambridge, UK) were maintained in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% (v/v) fetal bovine serum 
(FBS) and 100 μg/ml penicillin and streptomycin. Ras12V cells were 
generated from RIE-1 cells as described previously [6]. Sources for 
inhibitors were as follows: PD98059 was purchased from 
EMB4Biosceinces (Rockland, MA). CGP57380 was purchased from 
Tocris Bioscience (Ellisville, MO). Rapamycin was obtained from the 
Developmental Therapeutics Program of the National Cancer Institute. 
Western blot analysis 
Cells were plated and treated with inhibitors in DMSO as 
described in the figure legends, then extracted in RIPA buffer 
(EMB4Bioscience). Total cellular protein (20μg) was used for analysis. 
Membranes were probed using a purified rabbit polyclonal antibody 
raised against a 6Xhis-Tagged ODC protein as described previously 
[3], or a mouse monoclonal antibody against HuR (Santa Cruz Biotech, 
Santa Cruz, CA). Other antibodies used were as follows: GAPDH, 
4EBP1, S6K1 and ERK1/2 polyclonal antibodies (Cell Signaling 
Technology, Danvers, MA); Actin and Lamin B polyclonal antibodies 
(Santa Cruz Biotech). To prepare cytoplasmic and nuclear extracts, 
cells were fractionated using the Pierce Fractionation Kit as per the 
manufacturer’s instructions (Pierce, Rockford, IL). 
Generation of pGL3-ODC3′UTR constructs 
The full-length construct was made by PCR amplification of the 
735 base ODC 3′UTR from Ras12V cells and ligation into the pGL3-
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control expression vector (Promega, Madison, WI). Orientation of the 
3′UTR was confirmed by sequencing. Deletion mutants of the ODC 
3′UTR were constructed by PCR using the same template and 
antisense primers designed to produce deletions from the distal end of 
the 3′UTR. 
Immunoprecipitation analysis of translation initiation 
factors and Methyl-7-GTP sepharose chromatography 
Ras12V cells (7×105 cells/plate) and RIE-1 cells (9×105 
cells/plate) were plated on 10cm plates, allowed to adhere overnight 
and extracted 24h later. For inhibitor treatments Ras12V cells were 
treated for 2 h with either DMSO or 100 nM rapamycin after 24 h of 
growth. Cell extracts were prepared as described previously [18]. 
Polysome analysis 
Polysome analysis was carried out as described previously [19] 
using 9×105 RIE-1 or 7×105 Ras12V cells per 10 cm plate. Analysis 
was performed after 24 h of growth. Sucrose gradients (20–47%) 
were centrifuged at 34000 rpm for 5 h using a SW41 rotor (Beckman 
Coulter, Brea, CA). Absorbance was followed at 254 nm. A total of 11 
fractions were collected every 30 sec. For each fraction equal volumes 
of RNA were analyzed by Northern blot hybridization. Integrity of RNA 
was ensured by staining formaldehyde agarose gels with Ethidium 
bromide. 
Synthesis of radiolabeled cDNA probes 
cDNA probes were prepared by radiolabeling 100ng DNA with 
[32-P]-dCTP using the Rad prime DNA kit (Invitrogen, Carlsbad, CA) 
according to the manufacturer’s instructions. A full-length ODC probe 
was prepared from pGEM-ODC [3]. To prepare probes complementary 
to eEF1A and Cyclophilin, RNA from Ras12V cells was reverse 
transcribed and amplified by PCR. 
RNA stability assay 
Cells were cultured on 10 cm plates similar to polysome 
analysis. After 24 h of growth cells were treated with 5μg/ml 
Actinomycin D (Sigma-Aldrich, St. Louis, MO) and RNA was isolated at 
defined time points using the RNAqueous kit (Ambion, Austin, TX). 
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Northern analysis was carried out using 20 μg total RNA and 
radiolabeled cDNA probes synthesized for ODC and Cyclophilin as 
described above. Half-life of ODC RNA was determined by curve fit 
analysis. For Ras12V cells an approximate half-life was determined by 
extrapolation. Stability of pGL3-ODC3′UTR and mutant transcripts 
were compared by Northern blot analysis using a [32-P]-labelled firefly 
luciferase probe following transfection into RIE-1 and Ras12V cells. 
siRNA experiments 
Previously validated rat mTOR siRNA and scrambled control 
oligonucleotides [20] were synthesized, annealed in vitro and 
transfected using oligofectamine (Invitrogen) at 80 nM final 
concentration into Ras12V cells. At 48 h after transfection, 
Actinomycin D was added to the cells and stability of the ODC RNA was 
measured as described above. Extent of mTORC1 knockdown was 
assessed by measuring levels of hyperphosphorylated 4EBP1 by 
Western blot. 
Biotin-labeled RNA protein-binding assays 
A synthetic ODC transcript was generated by isolating total RNA 
from Ras12V cells, then using reverse transcriptase to produce cDNA. 
The cDNA was used as a template for PCR amplification of the full 
length 3′UTR of ODC. The 5′ primer sequence began with the T7 RNA 
polymerase promoter sequence (T7): 
CCAAGCTTCTAATACGACTCACTATAGGGAGA to allow further 
amplification. The ODC 3′UTR was amplified and PCR products were 
purified and used as templates to transcribe biotinylated RNA using T7 
RNA polymerase in the presence of biotinylated CTP [21]. The GAPDH 
3′UTR was amplified in the same manner for use as a negative control. 
The resulting biotinylated products were used in RNA pull-down assays 
essentially as described [22]. Western blot analysis was used to 
examine the association of HuR with the pull-down materials. For 
analysis of HuR binding to the DEL02 truncation mutant, biotinylated 
probes were synthesized and analyzed as described previously [17]. 
Mutation of the AUUUA sequence to GGGUA was by site-directed 
mutagenesis using the Quikchange Mutagenesis Kit as per the 
manufacturer’s instructions (Stratagene, La Jolla, CA). 
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Ribonucleoprotein immunoprecipitation (RNP IP) 
For immunoprecipitation of endogenous RNA-protein binding 
complexes, 2000 μg of cytoplasmic lysate was incubated for 2 h at 
room temperature with 50% (v/v) suspension of Protein A-Sepharose 
beads (Sigma-Aldrich) that had been pre-coated with 30 μg of either 
mouse IgG (Invitrogen) or HuR antibodies as described [23]. The 
immunoprecipitated material was analyzed by washing the beads with 
NT-2 buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM MgCl2, and 
0.05% Nonidet P-40), and further incubated with 0.5 mg/ ml 
Proteinase K, NT-2 buffer, and 0.1% SDS for 15 min at 55°C. RNA was 
precipitated using phenol-chloroform extraction in the presence of 
glycoblue (Qiagen, Valencia, CA). RNA from the immumoprecipitation 
was then reverse transcribed to detect the presence of ODC mRNA. 
RESULTS 
Stabilization of ODC mRNA upon Ras transformation of 
RIE-1 cells 
RIE-1 cells and their Ras-transformed counterparts are a 
valuable model in which to study the regulation of cellular polyamines 
[22, 24, 25], The studies described here use RIE-1 cells stably 
expressing a constitutively active Ras12V mutant (Ras12V cells), 
which results in about a 25-fold induction in ODC activity, and empty 
vector parental controls [6]. To determine whether the increase in 
ODC activity observed could be explained by changes in ODC 
translation efficiency in response to Ras activation, polysome profiles 
were performed (Figure 1A). In addition to a slight shift in ODC RNA 
from lighter to heavier polysome fractions in Ras12V cells, which one 
would expect with increased translation initiation, we observed an 
increase in the amount of total polysome-associated RNA in the 
Ras12V cells in comparison to the control RIE-1 cells (Figure 1A). By 
normalizing the amount of ODC RNA in each fraction to the relatively 
constant levels of Cyclophilin RNA associated with polysomes in both 
Ras12V and RIE-1 cells, we observed a 5-fold increase in the amount 
of ODC RNA associated with the polysomal fractions in the Ras12V 
cells (Figure 1A). 
The increase in ODC RNA associated with polysomes may result 
from increased interaction with stabilizing RNA binding proteins (RBPs) 
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or changes in its interaction with microRNAs (miRNAs). We have 
recently shown that the ODC transcript is stabilized by the RBP HuR in 
cells derived from skin carcinomas [17]. To determine whether 
changes in rate of mRNA decay could contribute to the dramatic ODC 
activity induction seen in Ras12V cells, we examined ODC RNA stability 
in both cell lines after exposure to Actinomycin D. The t1/2 for RIE-1 
ODC RNA was 3.0 h (Figure 1B, C), while the t1/2 in Ras12V cells was 
calculated to be 23.7 h, indicating an 8-fold increase in stability 
(Figure 1B, 1C). Cyclophilin served as a control. 
Inhibition of mTORC1 results in modest changes in ODC 
translation efficiency and a marked increase in ODC 
mRNA decay 
We have shown that post-transcriptional regulation of ODC is 
dependent on mTORC1- controlled pathways in several experimental 
systems [3, 6]. Therefore, we were interested to determine whether 
treatment with rapamycin affected cap-dependent translation initiation 
of ODC in Ras12V cells. Treatment of Ras12V cells with rapamycin 
reduced ODC protein in a time-dependent manner to about 15% of 
protein levels found in untreated cells by 24 h (Figure 2A). This is in 
agreement with previous results showing inhibition of ODC enzyme 
activity by rapamycin in the same time frame [6]. 
Treatment with rapamycin for 2 h had only a modest effect on 
ODC translation efficiency (Figure 2B, 2C). On the other hand, the 
same treatment time inhibited translation of eEF1α by causing a shift 
in EF1α RNA from polysomal fractions to non-polysomal fractions 
(Figure 2B, 2C), confirming that rapamycin inhibited translation 
initiation of known targets in this time frame. Rapamycin treatment 
also increased the association of 4EBP1 with eIF4E as assayed by both 
IP analysis of eIF4E and by m7GTP sepahrose chromatography 
(Supplemental Figure 1). IP analysis revealed a decrease in the 
association of eIF4G with eIF4E as well (Supplemental Figure 1). These 
results together suggest that mTORC1 controls cap complex formation 
in Ras12V cells. Exposure of cells to rapamycin for 24 h also produced 
little change in ODC translation efficiency (Figure 2B, 2C), although 
this prolonged treatment caused both a dramatic decrease in ODC 
protein levels (Figure 2A) and an overall decrease in the levels of 40S, 
60S, and 80S ribosomal subunits (Figure 2B, 2C). 
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To determine whether mTOR-dependent pathways may be 
involved in ODC mRNA stability control, we examined the effect of 
rapamycin on ODC mRNA decay in Ras12V cells. Since treatment with 
rapamycin for either 2 h or 24 h had similar effects on ODC polysome 
profiles (Figure 2), we decided to mimic the constitutive down-
regulation of mTOR-dependent signaling previously observed in RIE-1 
cells [6] by treating the Ras12V cells with rapamycin for 24 h. In 
vehicle-treated cells, the ODC RNA was very stable, with a calculated 
half-life of over 15 h. In cells pre-treated with rapamycin (100 nM) the 
t1/2 was calculated to be about 6 h (Figure 3A, 3B). Rapamycin 
treatment does not change the half- life of ODC mRNA in RIE-1 cells 
(data not shown), consistent with the already low mTOR activity in 
these cells [6]. 
To investigate the contribution of other Ras-effector pathways to 
control of ODC mRNA decay, we used inhibitors of MEK (PD98059, 50 
μM) or the eIF4E kinase Mnk1 (CGP57380, 20 μM). We have shown 
previously that both MEK and Mnk1 contribute to ODC synthesis in 
Ras12V cells by enhancing internal ribosome entry site (IRES)-
mediated translation [6], and MEK-dependent pathways control ODC 
transcription [3]. However, the results shown in Figure 3A and 3B 
suggest that neither pathway appears to play a major role in 
controlling ODC mRNA stability. To confirm the specificity of each 
inhibitor for its target, we measured activation of both mTORC1 and 
MEK signaling. Treatment with rapamycin completely inhibited 
phosphorylation of S6K1 and reduced hyperphosphorylation of 4EBP1, 
indicating inhibition of mTORC1-dependent pathways (Figure 3C). 
Activation of ERK is also seen in rapamycin-treated cells, consistent 
with previous results showing up-regulation of the MEK-ERK signaling 
cascade upon S6K1 inhibition [26]. On the other hand, inhibition of 
MEK with PD98059, while abolishing ERK phosphorylation, had no 
effect on mTORC1 activity (Figure 3C). Although ERK can 
phosphorylate and inhibit TSC2, leading to activation of mTOR, we 
have shown previously that the levels of activated Akt in Ras12V cells 
are very high [6]. These results suggest that TSC2 is phosphorylated 
primarily by Akt in these cells. CGP57380, which we previously showed 
to be a very effective inhibitor of Mnk1 in Ras12V cells [6], had no 
effect on either mTORC1 or ERK signaling cascades (Figure 3C). 
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mTOR knockdown mimics the effect of rapamycin 
treatment on ODC mRNA decay 
To confirm the effect of rapamycin on the destabilization of ODC 
mRNA, we knocked down mTOR using an siRNA approach. Reduction 
in mTOR by siRNA results in inhibition of both mTORC1- and mTORC2-
dependent pathways, while mTORC2 is not sensitive to rapamycin in 
most (though not all) models of tumorigenesis [27, 28]. We estimated 
the extent of mTOR knockdown 48h after transfection by measuring 
the levels of both total and phosphorylated 4EBP1. When compared to 
4EBP1 levels in parental RIE-1 cells, both total 4EBP1 and its 
hyperphosphorylated gamma form were clearly increased in Ras12V 
cells transfected with a scrambled siRNA, consistent with increased 
mTOR activity and protein synthesis in Ras12V cells compared to RIE-1 
cells [6]. In contrast, hyperphosphorylated 4EBP1 was largely 
eliminated in Ras12V cells transfected with the mTOR siRNA (Figure 
4A). This result suggests that mTORC1 activity is effectively inhibited 
in the mTOR siRNA-transfected cells. 
To determine ODC message stability in the presence of mTOR 
knockdown, Actinomycin D was added and Northern analysis was 
performed using Ras12V cells transfected with either scrambled siRNA 
or mTOR siRNA. These results show that knockdown of mTOR 
destabilizes the ODC transcript compared to a scrambled siRNA that 
does not knock down mTOR (Figure 4B). Quantitation of the mRNA 
showed about a 15 h half-life in cells treated with a scrambled siRNA, 
and a 7 h half-life in cells exposed to an siRNA directed to mTOR 
(Figure 4C). These results are very similar to those obtained with 
rapamycin treatment (Figure 3) and confirm that pathways dependent 
on mTORC1 regulate the decay of the ODC mRNA in Ras12V cells. 
Endogenous HuR associates with the ODC 3′UTR in 
Ras12V cells in a rapamycin- dependent manner 
We have shown previously using keratinocyte-derived cell lines 
that the RBP HuR associates with the ODC 3′UTR and stabilizes the 
ODC message in carcinoma cells but not in non-transformed cells [17]. 
To confirm that those results are not limited to the skin, we first 
performed an experiment designed to determine the intracellular 
localization of HuR in unstimulated parental and Ras12V-transformed 
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RIE-1 cells (Figure 5A). While HuR was predominantly nuclear in both 
cell lines, there was significant accumulation of HuR in the cytoplasm 
as well. Quantitation of bands revealed about a 2-fold increase in 
cytoplasmic HuR in Ras12V cells compared to their non-transformed 
counterparts (Figure 5A, 5B). 
These results differ from those reported previously in 
keratinocyte-derived cells, where HuR was exclusively nuclear in 
normal keratinocytes, but present in both the nucleus and cytoplasm 
of carcinoma cells [17]. 
We assessed the intracellular association of ODC mRNA with 
HuR in parental RIE-1 cells and their Ras-transformed counterparts 
using RNP IP assays, which allow the association between HuR and its 
target mRNAs to be maintained. Interestingly, almost no ODC mRNA 
was bound to HuR in lysates from RIE-1 cells, in spite of the presence 
of HuR in the cytoplasm. On the other hand, a strong association 
between HuR and ODC was observed in Ras12V cells (Figure 5B), 
similar to our results in skin carcinoma cells [17]. The lack of 
association in RIE-1 cells was not due to the absence of ODC mRNA 
from RIE-1 lysates. Indeed, ODC message is clearly present in both 
cell lines (Figure 5B). 
Ras12V cells were next treated with 100 nM rapamycin for 1 h, 
8 h, or 24 h, then harvested and analyzed as described above. This 
concentration of rapamycin blocks phosphorylation of both of the 
mTORC1 targets 4EBP1 and S6-kinase in Ras12V cells ([6] and Figure 
3). We observed a time-dependent decrease in the amount of ODC 
message present in the HuR immunoprecipitate in the presence of 
rapamycin (Figure 5C), suggesting that HuR interaction with the ODC 
mRNA is mediated in an mTORC1-dependent manner. Further, the 
time course of reduction in HuR association with the ODC message 
corresponds to the change in ODC activity in rapamycin-treated cells 
shown in Figure 1. There was no measurable change in either total 
HuR or the ratio of nuclear to cytoplasmic HuR in Ras12V cells, even 
after 24 h exposure to rapamycin (Figure 5D). This is consistent with 
the observation that RIE-1 cells also contain HuR in both the nucleus 
and cytoplasm (Figure 5A), in spite of very low levels of mTOR activity. 
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Identification of cis-acting stability elements in the ODC 
3′UTR 
The regulation of mRNA decay involves interaction of trans-
acting factors with cis-acting sequences that confer stability to a 
transcript. Many cis-acting sequences contain AREs within them, and 
the ODC 3′UTRs from mouse, rat and human contain several 
sequences that would be identified as AREs within the first 300 bases 
after the termination codon (Supplemental Figure 2). Our previous 
results suggest that elements within this ODC 3′UTR proximal end are 
responsible for stabilizing the ODC message by interacting with HuR 
[17]. 
In order to identify cis-acting elements within the ODC 3′UTR, 
we constructed several expression vectors in which the firefly 
luciferase open reading frame is linked to the full length mouse ODC 
3′UTR sequence (pGL3-ODC3′UTR), or deletion mutants corresponding 
to those used previously for HuR binding studies [17]. Stability of 
pGL3- ODC3′UTR and deletion transcripts was compared following 
transfection. The half-life of RNA derived from a luciferase reporter 
construct containing the full-length ODC 3′UTR (725 bases) was 
approximately 22h in Ras12V cells but only 7.5h in RIE-1 cells (Figure 
6A). This is in good agreement with the half-life of the endogenous 
ODC transcript (Figure 1B). Deletions in the 3′UTR from the distal end 
showed that deleting the last 381 bases to create a 344 base long 
3′UTR (DEL01) had no effect on mRNA decay in Ras12V cells (Figure 
6A). However, when an additional 172 bases were deleted (DEL02, 
172 bases long), the ODC mRNA t1/2 decreased about 3-fold, and was 
not changed substantially by further deletion to create a 53 base long 
3′UTR (DEL03). Steady state mRNA levels of transcripts derived from 
all transfected vectors were not significantly different (data not 
shown), suggesting that transfection efficiencies for the four vectors 
were similar. 
Mouse, rat and human ODC 3′UTR sequences all contain one 
canonical 5′-AUUUA-3′ pentamer between bases 1857 and 1861 of the 
ODC transcript (Supplemental Figure 2, [17]). To determine if the 
presence of this pentamer influences HuR binding, we used 
biotinylated synthetic transcripts corresponding to our DEL02 construct 
containing either the wild-type AUUUA sequence, or a mutation of the 
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putative HuR binding site to GGGUA. The results show not only that 
HuR binds to the GGGUA-containing transcript, but it appears to 
associate more strongly when compared to the wild-type transcript 
(Figure 6B). 
DISCUSSION 
Previous experiments from our lab and others have 
demonstrated cap-dependent translational regulation of ODC in a 
fibroblast model. Our data reported here suggest that in response to 
Ras transformation of RIE-1 cells, rates of ODC translation initiation 
increase only slightly. However, ODC mRNA is markedly stabilized, and 
is available to be recruited onto polysomes, resulting in increased ODC 
synthesis. The clear increase in ODC mRNA stability observed is a 
potentially important component of the mechanism responsible for 
increasing ODC protein and activity in a variety of tumorigenic models. 
There are a number of reports in the literature demonstrating that 
both global mRNA stability and the stability of specific transcripts are 
functionally linked to translation, particularly during stress responses 
[29–32]. While the ODC transcript is much more stable in Ras12V cells 
compared to RIE-1 cells, the polysome distributions of endogenous 
ODC mRNA suggest that it is quite poorly translated in both cell lines, 
with most of the ODC mRNA present in early fractions corresponding 
to polysomes containing a small number of ribosomes. This supports 
the idea that increased mRNA stability in Ras12V cells plays an 
important role in the accumulation of ODC protein in these cells. 
Indeed, the 2–3 fold increase in transcription shown previously in 
Ras12V cells [6], coupled with the calculated 8-fold increase in RNA 
stability shown here, would potentially account for most of the 20–25-
fold increase in ODC enzyme activity that we have observed in RIE-1 
cells transformed by Ras [6]. 
Although the mechanisms controlling mRNA decay are only 
beginning to be understood, treatment with rapamycin results in 
destabilization of several target RNAs in mouse embryo fibroblasts and 
breast cancer cell lines [12, 13], suggesting an alternative method of 
post- transcriptional control by mTORC1-dependent pathways. In 
agreement with this, our results show that inhibition of mTORC1 in 
Ras12V cells destabilizes ODC mRNA while only modestly changing 
translation initiation of the ODC transcript. Further, treatment of 
Ras12V cells with rapamycin reduces association of the stabilizing RBP 
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HuR with the ODC transcript. Taken together with our previous results, 
which show a functional link between HuR binding and ODC mRNA 
stability [17], these data suggest that activation of mTORC1 may help 
regulate ODC transcript decay by directing the association of this 
stabilizing factor with cis-acting elements within the ODC sequence. 
Our data suggest that elements between base 1969 and base 
2141 of the ODC sequence are necessary to stabilize the ODC 
transcript. This includes the sequence that we identified previously as 
containing multiple HuR binding sites [17]. In this context, it is 
interesting to note that in the in vitro assay used for these 
experiments HuR is capable of binding to the DEL02 deletion mutant, 
yet this transcript is significantly less stable than the full length ODC 
3′UTR when transfected into Ras12V cells, suggesting that additional 
binding proteins are acting in concert or competition with HuR to 
control the decay of the ODC mRNA. This interpretation is supported 
by our results showing that endogenous HuR present in the RIE-1 
cytoplasmic lysate does not interact with the ODC 3′UTR. Although 
previous results suggest that the sub-cellular localization of HuR 
responds to changes in activity of AMP-activated protein kinase, which 
is upstream of mTOR [33, 34], we see no change in HuR localization in 
rapamycin-treated Ras12V cells even though association of HuR with 
the ODC transcript is decreased. This further supports the idea of 
other trans factors competing with HuR for binding to the ODC 
message. 
HuR binding to the ODC 3′UTR is not abolished by mutation of 
the consensus ARE sequence 5′-AUUUA-3′ to GGGUA, suggesting this 
is not an important site of interaction. While AUUUA is classically 
defined as a canonical ARE, other more heterogeneous AU- and U-rich 
sequences have also been shown to bind RBPs, including HuR [15], 
and consensus sequences controlling mRNA stability have not yet been 
strictly defined. It is also well known that the ODC 5′UTR has a 
profound affect on ODC translation [35–39], and a contribution of the 
5′UTR to transcript stability cannot be ruled out from these 
experiments. However, the RNA half-life of our 3′UTR full-length 
reporter plasmid is quite similar to the half-life of the endogenous ODC 
transcript in both cell lines. 
Neither the increased stability of ODC RNA and its recruitment 
into polysomes in Ras12V cells, nor the destabilization of the ODC 
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message in the presence of rapamycin, are fully reflected in the total 
RNA levels. One hypothesis to explain these observations is that in 
RIE-1 cells much of the ODC RNA is stored in cytoplasmic P-bodies, 
aggregates of translationally repressed mRNA that are associated with 
decapping and deadenylation machinery. Upon activation of Ras-
dependent pathways, ODC RNA is released from these bodies to be 
recruited into polysomes in an mTOR-dependent manner. This notion 
is plausible, as it has been shown that P-bodies are dynamic foci that 
are able to assemble and disassemble based upon changes in cellular 
conditions [40]. Other studies have suggested that HuR may interact 
with miRNAs through an interdependent mechanism that causes 
release of specific transcripts from P-bodies and their entry onto 
polysomes in response to various types of cellular stresses [41]. 
Although application of a genome-wide target prediction algorithm 
[42] predicts that several miRNAs may interact with the ODC 3′UTR 
with favorable energies, a role for miRNAs in ODC post-transcriptional 
regulation has not been defined. 
In conclusion, we have demonstrated that, analogous to other 
growth regulatory proteins such as Cyclin D1, VEGF and c-Myc, the 
synthesis of ODC can be regulated at the levels of both mRNA 
translation and mRNA stability [23, 43–45]. Changes in ODC mRNA 
stability are at least partly dependent on the activity of mTORC1, 
which we show for the first time can not only regulate initiation of ODC 
translation but can also control ODC mRNA decay. Binding of the 
stabilizing RBP HuR to the ODC transcript is reduced when mTORC1 is 
inhibited, suggesting that mTOR-dependent pathways regulate this 
association, and possibly that of additional RBPs. Thus, these 
experiments extend our previous findings [17] to further define the 
mechanism by which ODC synthesis is controlled, and identify 
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Supplemental figure 2 
 
Supplemental figure legend 
Supplemental Figure 1. 
Rapamycin treatment inhibits cap complex formation in Ras12V cells. 
Plates grown in parallel with those shown in Figure 2A were harvested 
and subjected to either IP analysis or m7GTP sepharose 
chromatography. (A) Using IP of total eIF4E, the amount of 4EBP1 or 
eIF4G associated with eIF4E was determined by Western blot analysis. 
IP analysis using mouse IgG served as a negative control. (B) m7GTP 
sepharose chromatography was performed and the amount of eIF4E or 
4EBP1 associated with the m7GTP cap was analyzed by 
immunoprecipitation. 
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Supplemental Figure 2. 
Alignment of the proximal mouse, rat and human ODC 3’UTRs. 
Potential AREs, either 5’-AUUUA-3’ pentamers or extended AU-rich 
regions, are shown in boxes. 
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Figure 1. Analysis of ODC RNA translation and stability 
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(A) Polysomal analysis of ODC RNA was carried out in both RIE-1 and Ras12V cells as 
described in the Experimental section. Equal volumes of RNA were loaded per lane and 
Northern blots were probed with radiolabeled cDNA complementary to full length ODC, 
then stripped and reprobed with cDNA complementary to cyclophilin (Cyclo). The 
experiment was performed in duplicate with reproducible results. (B) To measure RNA 
stability, cells were treated with either 5 μg/ml Actinomycin D (Act D) or DMSO 
vehicle. RNA was isolated immediately after addition of Act D at 0 h and thereafter at 
2, 4, 6 and 8 h and at 8 h for DMSO-treated cells. For Northern analysis, 20μg of total 
RNA was loaded per lane and probed for ODC and cyclophilin simultaneously. The 
experiment was performed in duplicate with reproducible results. (C) Quantitation of 
the results presented in (B). The absolute values for absorbance corresponding to 
time=0 were 5.21 for Ras12V cells and 2.10 for RIE-1 cells (arbitrary units). 
 
Figure 2. Effect of mTOR inhibition on ODC translation initiation and 
protein levels in Ras12V cells 
(A) Cells were treated with either DMSO or 100 nM rapamycin (Rap) for the times 
indicated and harvested for Western blots of ODC protein as described in the 
Experimental section. Quantitation of bands was performed by densitometry and 
expressed as a fraction of the band corresponding to untreated cells (−). GAPDH 
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served as a control. (B) Cells were treated with either DMSO or 100 nM rapamycin for 
the times indicated and polysome analysis was carried out as described in the 
Experimental section. Northern blots were simultaneously probed for ODC and 
Cyclophilin, then were stripped and reprobed for eEF1A. The experiment was 
performed in duplicate with reproducible results. (C) Quantitation of the polysome 




Figure 3. Effect of Ras downstream signaling inhibition on ODC mRNA decay 
(A) Stability of ODC RNA was analyzed as described in Figure 1, except 100 nM 
rapamycin, 50 μM PD98059, 20 μM CG57380 or vehicle DMSO were added 24 h before 
the addition of Actinomycin D (ActD). RNA was collected immediately after addition of 
ActD at 0 h, and 4 h and 8 h later. (B) Quantitation of the results in (A). The absolute 
values for absorbance corresponding to time=0 were as follows: DMSO=2.11; 
Rapamycin=1.84; PD98059=1.49; CGP57380=2.00 (arbitrary units). (C) Cells were 
treated with inhibitors at the concentrations described in (A), harvested after 24 h in 
RIPA buffer, and analyzed for 4EBP1 and P-S6K1 as a measure of mTORC1 activity 
and P-ERK1/2 as a measure of MEK activity. P-S6K1 and P-ERK1/2 blots were then 
stripped and re-probed for total protein. All experiments were performed in duplicate 
or triplicate with reproducible results. 
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Figure 4. Regulation of ODC RNA stability by mTOR-dependent pathways 
(A) Knockdown of mTOR with siRNA was performed as described in the Experimental 
section. Extent of mTORC1 knockdown was assessed by measuring the levels of 
hyperphosphorylated 4EBP1 using Western blot analysis and comparing to parental 
RIE-1 cells. (B) ODC mRNA stability in the presence of siRNA directed against mTOR 
or a scrambled control siRNA was measured by Northern blot analysis.                           
(C) Quantitation of the results in (B). All experiments were performed in duplicate 
with reproducible results. 
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Figure 5. The mRNA binding protein HuR associates with the ODC 
transcript in Ras12V cells in a rapamycin-dependent manner 
(A) RIE-1 and Ras12V cells were fractionated into cytoplasmic and nuclear extracts 
and HuR localization was detected by Western blot analysis. Actin was used as a 
cytoplasmic marker and Lamin B was used as a nuclear marker. Band quantitation 
estimated a 2-fold increase in cytoplasmic HuR in Ras12V cells. (B) Cytoplasmic 
lysates from Ras12V and RIE-1 cells were used for RNP IP analysis with anti-HuR or 
nonspecific mouse IgG. RNA in the IP material was extracted with phenol-chloroform, 
used in a PCR reaction, and visualized on a 2% agarose gel. The levels of ODC mRNA 
were assessed by PCR using primers specific for the coding region. The same primers 
were used to estimate the amount of input RNA using cDNA derived from each cell 
line as a template. The experiment was conducted in triplicate with reproducible 
results. (C) The RNP IP experiment described in was repeated using Ras12V cells that 
had been pre-treated for 1 h, 8 h, or 24 h with 100 nM rapamycin or with DMSO 
vehicle for 24 h. Input RNA was assayed in cells treated with rapamycin or DMSO for 
24 h. The experiment was conducted in triplicate with reproducible results. (D) 
Nuclear/cytoplasmic fractionation was performed as described in (A) using Ras12V 
cells treated with rapamycin or DMSO vehicle for 24 h. GAPDH served as cytoplasmic 
marker and Lamin B served as nuclear marker. 
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Figure 6. The ODC 3′UTR contains a cis-acting RNA stability element 
(A) Cells were grown for 48 h then transfected with luciferase expression plasmids 
containing either the full length ODC 3′UTR or one of three 3′UTR deletion constructs, 
as shown in the schematic representation. RNA half-life was measured 48 h later as 
described in Figure 1. Results are from 2–5 independent experiments. Where two 
experiments were performed, results from both experiments are shown, others are the 
means ± SEM. (B) Ras12V cytoplasmic lysate (120 μg) was incubated with 15 μl of 
biotin-labeled synthetic probes corresponding to the DEL02 sequence containing either 
the wild-type (AUUUA) or mutated (GGGUA) ARE and Western blot for HuR was 
performed. The full length 3′UTR (FL) was used as a positive control. Cytoplasmic 
lysate (cyto) is also shown. This experiment was done in duplicate with similar results. 
 
